113 related articles for article (PubMed ID: 24099567)
1. Cytokines in terms of QSAR. Review, evaluation and comparative studies.
Konstantinidou M; Hadjipavlou-Litina D
SAR QSAR Environ Res; 2013 Nov; 24(11):883-962. PubMed ID: 24099567
[TBL] [Abstract][Full Text] [Related]
2. QSAR models on H
Pontiki E; Hadjipavlou-Litina D
J Biomol Struct Dyn; 2017 Apr; 35(5):968-1005. PubMed ID: 26982393
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitors (HDACIs). Structure--activity relationships: history and new QSAR perspectives.
Pontiki E; Hadjipavlou-Litina D
Med Res Rev; 2012 Jan; 32(1):1-165. PubMed ID: 20162725
[TBL] [Abstract][Full Text] [Related]
4. Current trends in quantitative structure activity relationships on FXa inhibitors: evaluation and comparative analysis.
Kontogiorgis CA; Hadjipavlou-Litina D
Med Res Rev; 2004 Nov; 24(6):687-747. PubMed ID: 15250038
[TBL] [Abstract][Full Text] [Related]
5. QSAR by LFER model of HIV protease inhibitor mannitol derivatives using FA-MLR, PCRA, and PLS techniques.
Leonard JT; Roy K
Bioorg Med Chem; 2006 Feb; 14(4):1039-46. PubMed ID: 16213730
[TBL] [Abstract][Full Text] [Related]
6. Chalcones in cancer: understanding their role in terms of QSAR. II part.
Repanas A; Katsori AM; Hadjipavlou-Litina D
Mini Rev Med Chem; 2013 Jun; 13(7):952-70. PubMed ID: 22876949
[TBL] [Abstract][Full Text] [Related]
7. Thromboxane synthase inhibitors and thromboxane A2 receptor antagonists: a quantitative structure activity relationships (QSARs) analysis.
Kontogiorgis C; Hadjipavlou-Litina D
Curr Med Chem; 2010; 17(28):3162-214. PubMed ID: 20666724
[TBL] [Abstract][Full Text] [Related]
8. Current trends in QSAR on NO donors and inhibitors of nitric oxide synthase (NOS)*.
Kontogiorgis CA; Hadjipavlou-Litina D
Med Res Rev; 2002 Jul; 22(4):385-418. PubMed ID: 12111751
[TBL] [Abstract][Full Text] [Related]
9. QSAR by LFER model of cytotoxicity data of anti-HIV 5-phenyl-1-phenylamino-1H-imidazole derivatives using principal component factor analysis and genetic function approximation.
Roy K; Leonard JT
Bioorg Med Chem; 2005 Apr; 13(8):2967-73. PubMed ID: 15781406
[TBL] [Abstract][Full Text] [Related]
10. Lipoxygenase inhibitors: a comparative QSAR study review and evaluation of new QSARs.
Pontiki E; Hadjipavlou-Litina D
Med Res Rev; 2008 Jan; 28(1):39-117. PubMed ID: 17191217
[TBL] [Abstract][Full Text] [Related]
11. QSAR Studies of Nitric Oxide Synthase Inhibitors.
Tsopka IC; Hadjipavlou-Litina D
Curr Top Med Chem; 2023; 23(29):2723-2734. PubMed ID: 38093588
[TBL] [Abstract][Full Text] [Related]
12. Review in quantitative structure activity relationships on lipoxygenase inhibitors.
Eleni P; Dimitra HL
Mini Rev Med Chem; 2003 Aug; 3(5):487-99. PubMed ID: 12769699
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of novel hydroxyalkylaminomethylchromones for their IL-5 inhibitory activity.
Thanigaimalai P; Lee KC; Sharma VK; Yun JH; Kim Y; Jung SH
Bioorg Med Chem; 2010 Jul; 18(13):4625-9. PubMed ID: 20627591
[TBL] [Abstract][Full Text] [Related]
14. [3D-QSAR of antiinflammatory activities of 5,6-diaryl-2,3-dihydro-1-pyrrolizinone derivatives].
Zhao LQ; Yuan Y; Hu YD; Zhang T; Zhang SF; Li S
Yao Xue Xue Bao; 2001 May; 36(5):343-6. PubMed ID: 12584855
[TBL] [Abstract][Full Text] [Related]
15. QSAR analyses of 3-(4-benzylpiperidin-1-yl)-N-phenylpropylamine derivatives as potent CCR5 antagonists.
Roy K; Leonard JT
J Chem Inf Model; 2005; 45(5):1352-68. PubMed ID: 16180912
[TBL] [Abstract][Full Text] [Related]
16. TOPS-MODE based QSARs derived from heterogeneous series of compounds. Applications to the design of new anti-inflammatory compounds.
Pérez González M; Dias LC; Helguera AM; Rodríguez YM; de Oliveira LG; Gomez LT; Diaz HG
Bioorg Med Chem; 2004 Aug; 12(16):4467-75. PubMed ID: 15265497
[TBL] [Abstract][Full Text] [Related]
17. Comparative QSAR modeling of CCR5 receptor binding affinity of substituted 1-(3,3-diphenylpropyl)-piperidinyl amides and ureas.
Thomas Leonard J; Roy K
Bioorg Med Chem Lett; 2006 Sep; 16(17):4467-74. PubMed ID: 16806923
[TBL] [Abstract][Full Text] [Related]
18. C-QSAR: a database of 18,000 QSARs and associated biological and physical data.
Kurup A
J Comput Aided Mol Des; 2003; 17(2-4):187-96. PubMed ID: 13677485
[TBL] [Abstract][Full Text] [Related]
19. Quantitative structure -- activity relationships (QSARs) of thrombin inhibitors: review, evaluation and comparative analysis.
Kontogiorgis C; Hadjipavlou - Litina D
Curr Med Chem; 2003 Apr; 10(7):525-77. PubMed ID: 12678789
[TBL] [Abstract][Full Text] [Related]
20. 2D-QSAR and 3D-QSAR/CoMFA analyses of the N-terminal substituted anthranilic acid based CCK(1) receptor antagonists: 'Hic Rhodus, hic saltus'.
Hadjipavlou-Litina D; Braiuca P; Lassiani L; Pavan MV; Varnavas A
Bioorg Med Chem; 2009 Jul; 17(14):5198-206. PubMed ID: 19523833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
